Identification of patients taking NSAIDs at high risk for GI bleeding.

Cyclooxygenase-2 (COX-2) inhibitors are significantly more expensive than traditional nonsteroidal antiinflammatory drugs (NSAIDs) from an acquisition cost perspective.[1][1],[2][2] The Veterans Affairs Healthcare System uses a gastrointestinal (GI) risk-assessment tool to determine which patients